Karyopharm Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Karyopharm Therapeutics (KPTI) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Karyopharm Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Karyopharm Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Karyopharm Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $396k | 457k | 0.87 |
| 2023-09-30 | $1.2M | 907k | 1.34 |
| 2023-06-30 | $783k | 438k | 1.79 |
| 2023-03-31 | $632k | 162k | 3.89 |
| 2022-12-31 | $1.8M | 523k | 3.40 |
| 2022-09-30 | $602k | 113k | 5.34 |
| 2022-06-30 | $1.4M | 318k | 4.54 |
| 2022-03-31 | $3.7M | 519k | 7.20 |
| 2021-12-31 | $1.7M | 267k | 6.43 |
| 2021-09-30 | $3.5M | 609k | 5.82 |
| 2021-06-30 | $3.0M | 294k | 10.11 |
| 2021-03-31 | $1.5M | 146k | 10.53 |
| 2020-12-31 | $1.5M | 96k | 15.49 |
| 2020-09-30 | $3.0M | 204k | 14.60 |
| 2020-06-30 | $2.5M | 134k | 18.94 |
| 2020-03-31 | $141k | 7.3k | 19.28 |
| 2019-12-31 | $294k | 15k | 19.17 |
| 2019-09-30 | $2.0M | 204k | 9.62 |
| 2019-06-30 | $16k | 2.7k | 5.88 |
| 2019-03-31 | $16k | 2.7k | 5.88 |
| 2018-12-31 | $2.0M | 217k | 9.19 |
| 2018-09-30 | $243k | 14k | 16.97 |
| 2018-06-30 | $164k | 9.6k | 17.10 |
| 2018-03-31 | $267k | 20k | 13.62 |
| 2017-12-31 | $21k | 2.3k | 9.06 |
| 2017-09-30 | $147k | 13k | 11.01 |
| 2017-06-30 | $33k | 3.7k | 8.94 |
| 2017-03-31 | $18k | 1.4k | 12.90 |
| 2016-12-31 | $22k | 2.4k | 9.32 |
| 2016-09-30 | $26k | 2.6k | 10.04 |
| 2016-06-30 | $14k | 1.8k | 7.50 |
| 2016-03-31 | $19k | 1.9k | 10.00 |
| 2015-12-31 | $68k | 5.2k | 13.19 |
| 2015-09-30 | $6.7k | 470 | 14.29 |
| 2015-03-31 | $2.6M | 88k | 30.00 |